tazanolast

09/01/1992 - "From these results, it is suggested that tazanolast is effective in inhibiting airway hyperresponsiveness."
09/01/1992 - "Pretreatment with tazanolast (30-300 mg/kg) produced a dose-dependent inhibition of airway hyperresponsiveness induced by PAF inhalation, and significant inhibition (p < 0.05) was obtained with the drug (300 mg/kg). "
05/01/1998 - "We conclude that tazanolast significantly inhibits ozone-induced airway hyperresponsiveness in guinea pigs. "
05/01/1998 - "However, tazanolast administered after ozone exposure did not inhibit the airway hyperresponsiveness. "
05/01/1998 - "Tazanolast administered before ozone exposure at doses of 30, 100, or 300 mg/kg inhibited ozone-induced airway hyperresponsiveness in a dose-dependent manner. "